Search results for Tomaralimab
Tomaralimab, Abbexa, abx831411
Tomaralimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TLR2/CD282, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Tomaralimab is under investigation in clinical trial NCT01794663 (Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function).
Host
Human, Mouse
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Tomaralimab Biosimilar - Research Grade, ichor.bio, ICH5932
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Tomaralimab (HT188016), abinScience, HT188016
Host
Chimeric
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.